zigimond

C F S  - Information International     
 

Prevalence  of  CFS/ FM

go to front page

 

 

Prevalence figures - CDC

Dr. Reeves, CDC published 2007-figures estimating that 2.54% of the Georgia population suffers from CFS, which is 6 to 10 fold higher than previous population-based estimates in other geographic areas, reeves.etal07.txt, reeves.etal.07.txt. Very importantly Dr. Jason has commented on these figures, reeves.etal07.jason.txt. Also a Dr. P White has commented on the new figures, white07.txt.

 

Using ME/CFS prevalence data of 0.42 and indirect costs estimates from Reynolds et al. (2004), the direct and indirect cost of ME/CFS to society was estimated to be $18,677,912,000 for the community sample and $23,972,300,000 for the tertiary sample, jason.etal08.txt.

 

Earlier figures from Wichita: 235 cases per 100,000, ie  0,2% of the population, reyes.etal03.pdf, suggesting the US total figure being close to 800,000 cases.  Also the figure for CFS-like ilness was studied and accounted for 2.2 million cases. The distribution according to geography did not disclose clusters, bierl.etal04.txt, bierl.etal04.pdf.  These authors also studied the functional status of the interviewed patients,  solomon.etal03.txt,  solomon.etal03.pdf.

 

Most cases of CFS in the population are unrecognized by the medical community; persons diagnosed as having CFS may be different from persons with CFS in the general population, solomon.reeves04.txt, solomon.reeves04.pdf.

 

Prevalences for different definitions of self-reported lifetime fatigue ranged from 36.7% for any fatigue to 2.7% for chronic fatigue syndrome-like illness, furberg.etal05.txt, furberg.etal05.pdf (Data from 4591 female and male twins from the population-based Mid-Atlantic Twin Registry).

 

 

Prevalence figures and CFS Case Definition

The impact of wording and the lack of consensus on the CFS case definition,  Jason et al., 1999.  Also from Dr. Jason’s team comes this study on the gravity of symptoms depending on the place of referral, jason.etal03.txt, jason.etal03.pdf.

 

Prevalence in Other Countries

Sweden: 6-month prevalence of CFS-like illness was 2·36%, evengard.etal05.txt, evengard.etal05.pdf.

In the Netherlands a study with GP-reporting concluded CFS prevalence figures of 112 per 100,000 as a minimum figure,  Bazelmans et al., 1999.  An editorial discusses the prevalence of chronic fatigue and CFS in the general population, bleijenberg03.pdf.  A study on the working population found prevalence of CFS-like cases, 3.6 %, huibers.etal04.txt, huibers.etal04.pdf. 

 

Incidence of fatigue symptoms and diagnoses presenting in UK primary care from 1990 to 2001, gallagher.etal04.txt.

From Iceland a prevalence of 0 - 4.9%, depending on the criteria used, is presented,  Lindal et al., 2002.
From
Korea, 0.6%, kim.etal05.txt, kim.etal05.pdf and China a prevalence of 6.4%, yiu.qiu05.txt.

 

In Nigeria high prevalence figures were found, njoku.etal07.txt, njoku.etal07.pdf.

 

Adolescent CFS-like illness occurred at a rate of 4.4%, mears.etal04.txt, mears.etal04.pdf.

 

Jason's Prevalence Studies

CFS numbers from population studies have been reported by Dr. Jason's team of DePaul University, Oct. 1999,  Jason et al., 1999, summary,  and  Jason et al., 1999 (full paper).  These researchers find a 0.42% prevalence of CFS among random household members (i.e. 420 per 100,000), which is twice the number reported by the CDC at the time. 

Prevalence Studies FM

An Israeli study found a prevalence of 15% FM in patients from internal medicine wards,  Buskila et al., 2001.  A Spanish 2001-study found a 2.4 % FM prevalence in the general population,  Carmona et al., 2001.  FM figures in the US: Age-adjusted incidence rates were 6.88 cases per 1000 person-years for males and 11.28 cases per 1000 person-years for females, weir.etal06.txt.

 

A Japanese study in workers found 7 of 343 females (2.04%) and one of 196 males (0.51%) met the ACR criteria for FM, toda07.txt.
 


 
 

Index     Welcome     CFS case def.     Prevalence     Prognosis     Brain Inflam     Post-Polio     Hypotheses


This  website is 100% non-commercial and independent of  associations and  public authorities.
The site is owned and run by 
Mette Marie Andersen, MD